Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
about
Lipid nanoparticles for targeted siRNA delivery - going from bench to bedsideAchieving HIV-1 Control through RNA-Directed Gene RegulationHarnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.The delivery of therapeutic oligonucleotidesPotential inhibition of HIV-1 encapsidation by oligoribonucleotide-dendrimer nanoparticle complexes.Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses.Metabolic regulation of immune responses: therapeutic opportunities.Injectable nanofibrous spongy microspheres for NR4A1 plasmid DNA transfection to reverse fibrotic degeneration and support disc regeneration.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Microfluidics: a transformational tool for nanomedicine development and production.T memory stem cells in health and disease.Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerOptimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands.Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response.siRNA delivery: current trends and future perspectives.Evaluating Nanoparticle Binding to Blood Compartment Immune Cells in High-Throughput with Flow Cytometry.Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment.Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
P2860
Q26741449-4FABEEDF-FCDF-44C8-9A96-76A3D8D24013Q28080090-3C1EAC0C-0F86-4A0F-AF08-AF420D2A8F99Q36459323-68BCEAA8-CD42-43EA-8957-F6A476645C80Q37210936-624D6314-513A-421D-9337-0647B825D6A6Q37573734-6B087595-E0F4-488B-8166-C8D931989530Q37625459-2CADE59A-A66C-476E-B6FD-C1DB5D0EBBC9Q38471902-5DDBB7E6-3210-4D47-A230-E4EFEBFFA79CQ38850162-0D1F13B0-72FC-4DCC-A2D9-7D63A8885396Q38855505-16967C84-05FE-48CE-9732-B3AFAE19AD84Q38862946-4609A0C7-F009-4B4B-BD3F-6CDBBABC4CD8Q38918919-8E7765F4-8A2D-4DB5-BE9C-209FDE9C20EFQ39070577-A6995C83-4555-4EC6-A3A1-0DCD4A22AF59Q39230061-BCCF965C-F5A9-4FC1-A77E-F1D5B7863C82Q40735074-74BD96FF-62E8-447D-9016-A1073085D8C3Q42176588-C710ED98-30EE-4FC1-83A0-4E6F5EF67CADQ47225568-762D88EB-0118-4581-9D49-8472CE1BA660Q47566766-EA151860-75C4-42B9-A2AB-3510DF82794BQ47568930-74E6D3A5-2B85-4B18-9CB8-D89622EFA3BFQ51122151-17E992FA-337D-4540-8F0A-38134DF396FEQ52579251-D5F023AC-8329-4FA5-94B1-5ABF5D90E5EBQ58105699-E6BAE4F2-69D9-4837-878D-C19E6A1543F7
P2860
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
@en
type
label
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
@en
prefLabel
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
@en
P2093
P50
P356
P1433
P1476
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
@en
P2093
Andrew G Sprague
Derek M Dykxhoorn
Fransisca Leonard
Meir Goldsmith
Pieter R Cullis
Ranit Kedmi
Srinivas Ramishetti
P304
P356
10.1021/ACSNANO.5B02796
P407
P577
2015-06-10T00:00:00Z